EMPLOYMENT AGREEMENTEmployment Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledNovember 29th, 2013 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the 9th day of October, 2013, by and between Recro Pharma, Inc., a Pennsylvania corporation (the “Company”), and Donna Nichols, an individual (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledNovember 29th, 2013 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the 8th day of October, 2013, by and between Recro Pharma, Inc., a Pennsylvania corporation (the “Company”), and Gerri Henwood an individual (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledNovember 29th, 2013 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the 8th day of October, 2013, by and between Recro Pharma, Inc., a Pennsylvania corporation (the “Company”), and Randall Mack an individual (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledNovember 29th, 2013 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the 27th day of November, 2013, by and between Recro Pharma, Inc., a Pennsylvania corporation (the “Company”), and Diane Myers, an individual (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 29th, 2013 • Recro Pharma, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledNovember 29th, 2013 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the ninth day of October, 2013, by and between Recro Pharma, Inc., a Pennsylvania corporation (the “Company”), and Charles Garner, an individual (the “Executive”).